CaƱada, Jeneth B.
HRN: 16-41-87 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/20/2022
CEFUROXIME 500MG (TAB)
09/20/2022
09/27/2022
PO
500mg
Q12
UTI
Waiting Final Action
Indication: EmpiricEmpirical De-escalation Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes